Delhi HC seeks Centre’s response on delay in safety review of acidity drug Ranitidine
In his petition, Jain contended that the safety of Ranitidine remained an unresolved concern since September 2019
We haven't written up this one. Hindustan Times has the full story — the link below goes straight to it.